Ming-Kuei Jang
Chief Executive Officer at Aprinoia Therapeutics, Inc.
Profile
Ming-Kuei Jang is the founder of Aprinoia Therapeutics, Inc. (founded in 2015) where he holds the title of Chief Executive Officer.
He is also the founder of Aprinoia Therapeutics, Inc. (founded in 2015) where he holds the title of Chairman & President-Asia Operations.
Currently, Dr. Jang is the Chief Scientific Officer at APRINOIA Therapeutics LLC.
In the past, he worked as an Associate Director at Glaxosmithkline China Ltd.
from 2010 to 2012.
Dr. Jang completed his undergraduate studies at National Taiwan University and obtained a doctorate degree from Boston University School of Medicine.
Ming-Kuei Jang active positions
Companies | Position | Start |
---|---|---|
Aprinoia Therapeutics, Inc.
Aprinoia Therapeutics, Inc. BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a drug discovery and early development company. The company was founded by Ming-Kuei Jang in May 20, 2015 and is headquartered in Taipei, Taiwan. | Chief Executive Officer | 2015-05-19 |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Founder | 2014-12-31 |
APRINOIA Therapeutics LLC | Chief Tech/Sci/R&D Officer | - |
Former positions of Ming-Kuei Jang
Companies | Position | End |
---|---|---|
Glaxosmithkline China Ltd. | Corporate Officer/Principal | 2012-02-29 |
Training of Ming-Kuei Jang
Boston University School of Medicine | Doctorate Degree |
National Taiwan University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
Health Technology |
Private companies | 3 |
---|---|
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Health Technology |
APRINOIA Therapeutics LLC | |
Glaxosmithkline China Ltd. |
- Stock Market
- Insiders
- Ming-Kuei Jang